Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice. | Cell Commun Signal | 2023 | 37946301 | PubTator, text mining | PubMed |
| Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases. | Genome Med | 2023 | 37946251 | PubTator, text mining | PubMed |
| A genomic perspective of the aging human and mouse lung with a focus on immune response and cellular senescence. | Immun Ageing | 2023 | 37932771 | PubTator, text mining | PubMed |
| FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review. | Front Oncol | 2023 | 37916161 | PubTator, text mining | PubMed |
| Soluble immune checkpoints are elevated in patients with primary biliary cholangitis. | Eur J Med Res | 2023 | 37915081 | PubTator, text mining | PubMed |
| Investigation into the Relationship between Spermidine Degradation and Phenolic Compounds Biosynthesis in Barley Seedlings under Ultraviolet B Stress. | Plants (Basel) | 2023 | 37895996 | PubTator, text mining | PubMed |
| Exploring the Significance of Immune Checkpoints and EBV Reactivation in Antibody Deficiencies with Near-Normal Immunoglobulin Levels or Hyperimmunoglobulinemia. | Cancers (Basel) | 2023 | 37894426 | PubTator, text mining | PubMed |
| Comprehensive Systematic Review of Biomarkers in Metastatic Renal Cell Carcinoma: Predictors, Prognostics, and Therapeutic Monitoring. | Cancers (Basel) | 2023 | 37894301 | PubTator, text mining | PubMed |
| Linkage between Psychological Factors and Response to Immune Checkpoint Inhibitor Therapy: A Preliminary Study. | Cells | 2023 | 37887315 | PubTator, text mining | PubMed |
| Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients? | Cancers (Basel) | 2023 | 37835480 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma. | Aging (Albany NY) | 2023 | 37827698 | PubTator, text mining | PubMed |
| Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts. | Front Immunol | 2023 | 37822926 | PubTator, text mining | PubMed |
| Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis. | World J Surg Oncol | 2023 | 37821941 | PubTator, text mining | PubMed |
| Gastric acid challenge of lithium disilicate-reinforced glass-ceramics and zirconia-reinforced lithium silicate glass-ceramic after polishing and glazing-impact on surface properties. | Clin Oral Investig | 2023 | 37821653 | PubTator, text mining | PubMed |
| Preliminary exploration of SKA1 expression in lung adenocarcinoma and its clinical significance. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37814813 | PubTator, text mining | PubMed |
| Progresses in biomarkers for cancer immunotherapy. | MedComm (2020) | 2023 | 37799808 | PubTator, text mining | PubMed |
Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1. | Bull Exp Biol Med | 2023 | 37773572 | PubTator, text mining | PubMed |
| Defining the condensate landscape of fusion oncoproteins. | Nat Commun | 2023 | 37770423 | PubTator, text mining | PubMed |
| Two Novel Frameshift Mutations in the GLI3 Gene Underlie Non-Syndromic Polydactyly in Chinese Families. | Genet Test Mol Biomarkers | 2023 | 37768332 | PubTator, text mining | PubMed |
| Can sPD-1 and sPD-L1 Plasma Concentrations Predict Treatment Response among Patients with Extraparenchymal Neurocysticercosis? | Pathogens | 2023 | 37764924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=10